CID 102170967

Anacyclamide a10

Structural Information

Molecular Formula
C49H72N12O14
SMILES
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCC(=O)N)CO)[C@@H](C)O)C(C)C)CO)CC4=CNC5=CC=CC=C54
InChI
InChI=1S/C49H72N12O14/c1-6-25(4)39-46(72)55-31(19-27-20-51-29-12-8-7-11-28(27)29)41(67)52-21-37(66)53-33(23-63)48(74)60-17-9-13-34(60)44(70)57-38(24(2)3)49(75)61-18-10-14-35(61)45(71)59-40(26(5)64)47(73)56-32(22-62)43(69)54-30(42(68)58-39)15-16-36(50)65/h7-8,11-12,20,24-26,30-35,38-40,51,62-64H,6,9-10,13-19,21-23H2,1-5H3,(H2,50,65)(H,52,67)(H,53,66)(H,54,69)(H,55,72)(H,56,73)(H,57,70)(H,58,68)(H,59,71)/t25-,26+,30-,31-,32-,33-,34-,35-,38-,39-,40-/m0/s1
InChIKey
TWBVBKLXMJGRPJ-WTPCWRIRSA-N
Compound name
3-[(3S,6S,12S,18S,21S,24S,27S,30S,33S)-21-[(2S)-butan-2-yl]-30-[(1R)-1-hydroxyethyl]-12,27-bis(hydroxymethyl)-18-(1H-indol-3-ylmethyl)-2,5,11,14,17,20,23,26,29,32-decaoxo-3-propan-2-yl-1,4,10,13,16,19,22,25,28,31-decazatricyclo[31.3.0.06,10]hexatriacontan-24-yl]propanamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

8
Patents

1052.529 Da
Monoisotopic Mass

-0.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 1053.5363 283.1
[M+Na]+ 1075.5182 283.9
[M-H]- 1051.5217 268.7
[M+NH4]+ 1070.5628 277.9
[M+K]+ 1091.4922 269.8
[M+H-H2O]+ 1035.5263 251.0
[M+HCOO]- 1097.5272 278.2
[M+CH3COO]- 1111.5429 280.6
[M+Na-2H]- 1073.5037 270.3
[M]+ 1052.5285 283.9
[M]- 1052.5295 283.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe